The Medical Center of the Americas Foundation is committed to increasing activity within Industry Sponsored Clinical Trials across the El Paso, Texas; Juarez, Mexico, and southern New Mexico region. It is our mission to cultivate a dynamic biomedical industry and a globally competitive innovation/entrepreneurship ecosystem.
Clinical trials are a critical step in the process of bringing new treatments to patients. New medicines and therapies must undergo rigorous testing before they are approved for use by the FDA on human subjects. After successful animal studies, research moves into clinical trials, which involves the research and study of human subjects that assess the safety or efficacy of a drug, device, diagnostic, treatment, preventive measure, or similar intervention through testing on patients in a clinical setting.
The following trends are shaping the future of clinical research:
The industry looks to bridge the gap between healthcare and research so that clinical research will be presented as a care option during a patient's standard office visit. In other words the future of the clinical trial industry is expanding beyond academic medical center settings to cast a broader net through the convenience of the patient’s home or medical clinic. Competitive clinical trial hubs will effectively increase a patient's access to trials and integrate clinical research into the continuum of care.
The process of bringing a new drug or device to market is too slow, too costly and inefficient. Therefore, we are actively scanning the industry for solutions that can support a more efficient drug development process.
patient access to life saving, cutting edge therapeutics and diagnostics.
innovations & technology to improve patient recruitment, trial efficiency, performance & quality.
world class research talent, high quality trial sites and centers of excellence.
better care, better outcomes and improved health and wellness for patients and make a significant contribution to the global community.
If you are a leader of healthcare, academic, or clinical research institution based in the Borderland region, please consider becoming a part of the region's COVID-19 Clinical Trial Taskforce looking to accelerate patient access to innovative COVID-19 diagnostics and treatments as they become available. This Taskforce meets bi-monthly or every other Thursday 1-2 PM. Participation in the task force is by invitation only. Please contact Michaele@mcamericas.org if you wish to participate or for more information.
Please encourage COVID-19 survivors to become a convalescent plasma donor!
Many of our region's healthcare institutions are participating in the US national expanded access COVID-19 convalescent plasma project led by the May Clinic and the COVID-19 Convalescent Plasma Alliance looking to bring new COVID-19 therapeutics to market. If you have recovered or know of someone who has recovered from COVID-19, please consider donating blood to the following blood banks needed to replenish our region's supply of COVID-19 antibodies, which could be the difference between life and death for those infected with the coronavirus.
Thank you for helping us spread us to the word. Your efforts will ensure our region's supply of COVID-19 antibodies derived from convalescent plasma is replenished as the need grows these next few months.
The Paso del Norte region is made up of El Paso, Texas; Juarez, Mexico and southern New Mexico – a metroplex with a unique and desirable demographic for medical research. The combination of a high population density, a low number of current clinical trials, prevalent Hispanic population, and a growing healthcare market makes the Paso del Norte region an appealing hub for expanded clinical-research opportunities.